Branda R F, Miller W J, Soltis R D, McCullough J J
Transfusion. 1986 Sep-Oct;26(5):471-7. doi: 10.1046/j.1537-2995.1986.26587020129.x.
Four patients with refractory acute leukemia were treated a total of 31 times with an immunoadsorption system consisting of protein A-sepharose columns, a cell separator, and an elution monitor to test its safety and capacity to remove immunoglobulins. The procedure was tolerated well, and acutely reduced plasma IgG levels by approximately 18 percent. When the procedure was repeated two to three times per week for 3 weeks, IgG levels dropped by 30 to 40 percent, but they gradually returned to pretreatment levels after completion of the course of treatment. Single columns became saturated with IgG after approximately 1500 ml of plasma had passed through the columns. The use of multiple columns sequentially provided continuous extraction of immunoglobulin. One patient regained responsiveness to platelet transfusions after removal of platelet antibodies. These preliminary studies suggest that this immunoadsorption system is effective for specifically removing IgG and that it merits further clinical testing.
四名难治性急性白血病患者使用由蛋白A-琼脂糖柱、细胞分离器和洗脱监测器组成的免疫吸附系统共进行了31次治疗,以测试其安全性和去除免疫球蛋白的能力。该操作耐受性良好,可使血浆IgG水平急性降低约18%。当每周重复该操作两到三次,持续3周时,IgG水平下降了30%至40%,但在治疗过程结束后逐渐恢复到治疗前水平。大约1500毫升血浆通过柱子后,单个柱子会被IgG饱和。依次使用多个柱子可实现免疫球蛋白的持续提取。一名患者在去除血小板抗体后恢复了对血小板输注的反应性。这些初步研究表明,这种免疫吸附系统对于特异性去除IgG是有效的,值得进一步进行临床试验。